ARHGEF15 and neoplasm: Collectively, these findings suggest that heterogeneity in E5 expression may impact tumor immune evasion and influence therapeutic response, underscoring the need for molecular subclassification to improve prognostic stratification and guide targeted therapeutic strategies.